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Our recent observation that hepatitis B virus (HBV) DNA polymerase (P) might initiate minus-strand DNA synthesis without primer [Kim et
al., (2004) Virology 322, 22–30], raised a possibility that HBV P protein may have the potential to function as an RNA polymerase. Thus, we
mutated Phe 436, a bulky amino acid with aromatic side chain, at the putative dNTP-binding cleft in reverse transcriptase (RT) domain of P
protein to smaller amino acids (Gly or Val), and examined RNA polymerase activity. HBV core particles containing RT dNTP-binding cleft
mutant P protein were able to incorporate 32P-ribonucleotides, but not HBV core particles containing wild type (wt), priming-deficient mutant, or
RT-deficient mutant P proteins. Since all the experiments were conducted with core particles isolated from transfected cells, our results indicate
that the HBV RT mutant core particles containing RT dNTP-binding cleft mutant P protein could incorporate both deoxyribonucleotides and
ribonucleotides in replicating systems.
© 2007 Elsevier Inc. All rights reserved.Keywords: Hepatitis B virus; Core particles; Reverse transcriptase; dNTP-binding cleft mutant; Ribonucleotide incorporations; Endogenous polymerase activityIntroduction
Hepadnaviruses are small, enveloped DNA viruses that
replicate preferentially in liver cells, and are involved in acute
and chronic hepatitis, cirrhosis, and hepatocellular carcinoma
(HCC) (Brechot, 2004), and they utilize a unique replication
strategy that involves reverse transcription of a pregenomic
RNA (pgRNA) (Seeger and Hu, 1986). Hepatitis B virus
(HBV), a prototype hepadnavirus, has a partially duplex,
relaxed circular DNA genome with overlapping reading frames
encoding the core (C, HBc), polymerase (P), surface (S, HBs),
and X (HBx) proteins.
The multifunctional hepadnavirus P protein functions in
DNA synthesis and encapsidation of pgRNA (Bartenschlager et
al., 1990; Hirsch et al., 1990), and acts as a primer for minus-⁎ Corresponding author. Fax: +82 31 219 5079.
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doi:10.1016/j.virol.2007.08.018strand DNA synthesis (Wang and Seeger, 1992; Weber et al.,
1994; Zoulim and Seeger, 1994). The HBV P protein recognizes
the epsilon (ε) sequence (the encapsidation signal) of pgRNA
for encapsidation to form core particles with other viral and host
components. In addition, HBV P begins the protein-priming
reaction (initiation of reverse transcription), by using phospho-
diester bonds to covalently link the hydroxyl group of a Tyr in
the terminal protein (TP) with the first deoxyribonucleotide
(Lanford et al., 1997; Weber et al., 1994; Zoulim and Seeger,
1994) and the subsequent 2–3 deoxyribonucleotides of the
nascent minus-strand DNA, TGAA or GAA. The nascent
minus-strand DNA, TGAA or GAA, are synthesized from the
bulge of ε as template. Inside the core particle, the oligomer
which is covalently linked to TP translocates from ε to direct
repeat 1 (DR1) at the 3′-end of the pgRNA, and the minus-
strand DNA is subsequently elongated by reverse-transcription
of the pgRNA (Tavis and Ganem, 1995; Tavis et al., 1994). The
reverse-transcriptase (RT) reaction is a complex process
requiring an RNA-dependent DNA polymerase, a DNA-
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for the RNA:DNA hybrid. Although RT uses both RNA and
DNA as templates, it uses only dNTPs as substrates, but not
rNTPs.
It has traditionally been believed that the choice of
polymerase (DNA vs. RNA) is based upon the preferences for
deoxyribonucleotides (dNTPs) or ribonucleotides (rNTPs) as
substrates for incorporation during nucleic acid synthesis.
Crystallographic studies revealed that the DNA and RNA
polymerases had remarkable similarities in their structures,
including the presence of a characteristic protein fold that forms
a nucleic acid binding cleft and catalytic mechanisms (Hansen
et al., 1997; Jacobo-Molina et al., 1993; Joyce and Steitz, 1994;
O'Reilly and Kao, 1998). Conserved motif A is found in all
kinds of nucleic acid polymerases, including RNA-dependent
RNA and DNA polymerases and DNA-dependent RNA and
DNA polymerases. Among them, DNA polymerases, including
DNA polymerase α (a DNA-dependent DNA polymerase) and
RT, have a bulky amino acid, such as Glu, Tyr, or Phe, in the
dNTP-binding cleft of conserved motif A (Fig. 1A) (Beck et al.,
2002; Cases-Gonzalez et al., 2000; Gao et al., 1997; Joyce,
1997). These bulky amino acid residues are believed to be
crucial for the selection of dNTPs, instead of rNTPs, by acting
as a steric gate to prevent the incorporation of rNTPs, which
have a larger ribose at the 2′-hydroxyl group, into the dNTP-
binding cleft (Beck et al., 2002; Cases-Gonzalez et al., 2000;
Gao et al., 1997; Joyce, 1997). In contrast, the RNA
polymerases, such as the RNA-dependent RNA polymerases
(e.g. poliovirus 3Dpol) and the single subunit DNA-dependentFig. 1. Alignment of the polymerase domains of the HBV and DHBV P proteins, th
constructs. (A) Alignment of the polymerase domains of the HBV and DHBV P p
alignments of motif A. Individual domains of the various proteins are presented as o
located at their relative positions. Amino acid sequence alignments of motif A from
shown below. The conserved bulky amino acid of the RTs and the corresponding
arrowhead. (B) Schematic diagram of HBV wt and mutant constructs used for transie
the 5′- and 3′-ends are marked. The ORFs of the C, P, S, and X genes are presented as
are indicated. The cytomegalovirus (CMV) immediate early promoter is indicated wit
and RT YMHA in a wt HBV adw R9 background, which was previously described
changed to Gly or Val in a wt HBV adw R9 background are designated as RT F436G
protein are indicated by closed arrowheads.RNA polymerases (e.g. T7 RNA polymerase), have relatively
small residues at the corresponding position of conserved motif
A (Gly and Asp, respectively) (Fig. 1A) (Joyce, 1997). Several
studies have provided evidences blurring the polymerase
classes in terms of template specificity and nucleotide substrate
selectivity (Beck et al., 2002; Cases-Gonzalez et al., 2000; Gao
et al., 1997; Joyce, 1997). Mutational studies on the MMLV,
HIV-1 (human immunodeficiency virus type 1), and DHBV
(duck hepatitis B virus) RTs indicate that the bulky residues
with aromatic side chains at motif A (Phe 155, Tyr 115, and Phe
451, respectively) (Fig. 1A) act as a steric gate, providing dNTP
selectivity by preventing rNTPs (Beck et al., 2002; Cases-
Gonzalez et al., 2000; Gao et al., 1997).
In the present study, we examined the rNTP and dNTP
incorporations of HBV mutant P proteins which harbored Phe
436 to Gly or Val mutations in the putative dNTP-binding cleft,
using a modified endogenous polymerase assay (EPA) to test
the incorporation of rNTPs and/or dNTPs into HBV core
particles containing RT mutant P proteins. Our results showed
that the HBV RT mutants could incorporate both dNTPs and
rNTPs without exclusions. These results indicate that the
mutated HBV RT mutant P proteins have lost its normal
substrate selectivities and Phe 436 of HBV P acts as a steric gate
to prevent the incorporation of nucleotides with a 2′-hydroxyl
group. The previously identified primer-independent initiation
of HBV DNA synthesis (Kim et al., 2004) and the incorpora-
tions of rNTPs by mutant HBV P proteins collectively indicate
that the HBV P protein could acquire RNA polymerase-like
properties with only minor modifications.e HIV-1 and MMLV RTs, and a schematic diagram of the HBV wt and mutant
roteins, and the HIV-1 and MMLV RTs, along with the amino acid sequence
pen boxes, while conserved motifs 1/2 and A–E are presented as closed boxes
RT, human DNA polymerase α, T7 RNA polymerase, and poliovirus 3Dpol are
residue in the DNA and RNA polymerases are highlighted with a box and an
nt expression. HBV sequences are depicted as thick lines, and the ε sequences at
open boxes. The various domains (TP, spacer, RT, and RNase H) of the P protein
h an open arrow. HBV wt and mutant constructs, including TP Y65F, P-deficient,
(Kim et al., 2004), are shown. The HBV RT mutant constructs with Phe 436
and RT F436V, respectively. The positions of the point mutations within the P
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Sequence analysis of conserved motif A in HBV RT domain and
construction of HBV RT mutant P proteins
Amino acid sequence alignment of conserved motif A
among various polymerases indicated that the corresponding
amino acid in the dNTP-binding cleft of the HBV P protein is
Phe 436, which is located in the RT domain (Fig. 1A).
To investigate whether Phe 436 is responsible for the dNTP
selectivity of the HBV P protein, we replaced Phe 436 to smaller
Gly and Val residues, yielding RT F436G and RT F436V (Fig.
1B), respectively, and examined whether the DNA polymerase
activity was changed to that of an RNA polymerase in terms of
preferring rNTPs vs. dNTPs. As controls, we used the
following: HBV wt subtype adw R9; RT-reaction-deficient RT
YMHA, wherein the conserved YMDD motif of the RT active
site was modified to YMHA; priming-deficient TP Y65F, which
was previously shown to synthesize oligomers from encapsi-
dated pgRNA in the absence of covalent linkage between the
Tyr 65 of TP and the first deoxyribonucleotide; and P protein-
deficient mutants (Fig. 1B) (Kim et al., 2004).
HBV RNA expression, core particle formation, and pgRNA
encapsidation by HBV RT mutant P protein
Following transfection of the wt and mutant HBV constructs,
pgRNA was expressed by the action of the CMV promoter,
while subgenomic RNA sequences were synthesized under the
control of their authentic promoters. Northern blot analysis of
HBV RNA revealed that the 3.5 kb pgRNA, and 2.1 and 2.4 kb
surface protein mRNAs were expressed at comparable levels in
the wt- and mutant-transfected cells (data not shown). Northern
blot analysis was also performed to compare GAPDH mRNA
expression levels and there were no significant differences
between wt- and mutant-transfected cells (data not shown).
Native agarose gel electrophoresis followed byWestern blotting
with an anti-HBc antibody revealed that core particles were
formed at comparable levels in wt- and mutant-transfected
HuH7 cells (Kim et al., 2004; Koschel et al., 2000) (Figs. 2B–
D, 3, and 4). Then, we performed RPA to detect the cytoplasmic
and encapsidated pgRNAs from wt- and mutant-transfected
cells. We speculated that there should be no significant
alteration in the tertiary structures of the RT F436G and RT
F436V mutant P proteins except at the dNTP-binding cleft,
meaning that these RT mutants should encapsidate pgRNA at
levels comparable to those found with the HBV wt. As
expected, the comparable pgRNA encapsidations were
observed in core particles containing RT F436G, RT F436V,
RT YMHA, and wt HBV P proteins, whereas the encapsidation
of P protein-deficient mutant core particles (Kim et al., 2004)
was not observed (Fig. 2A, upper panel). There were no
significant differences in cytoplasmic pgRNAs between wt- and
mutant-transfected cells (Fig. 2A, lower panel). The generated
mutations in the dNTP-binding cleft of the HBV P protein do
not affect HBV RNA expression, core particle formation, or
pgRNA encapsidation.HBV DNA synthesis by RT F436G and RT F436V mutants
We speculated that the RT F436G and RT F436V mutants,
which should have enlarged dNTP-binding clefts, could
incorporate dNTPs with reduced selectivities compared to wt
HBV, and thus might synthesize HBV DNA. Southern blot
analysis revealed, however, that single-stranded, double-
stranded linear, and partially double-stranded relaxed circular
HBV DNAmolecules were detected in core particles from HBV
wt-transfected cells, but not in core particles from RT YMHA-,
RT F436G-, or RT F436V-transfected cells (Fig. 2B).
We previously showed that the TP Y65F mutant could
synthesize short DNA oligomers; however, these oligomers
were lost during conventional DNA purification of core
particles, and therefore, were not detected by Southern blot
analysis (Kim et al., 2004). Thus, we next applied EPA by
incubating the isolated wt and mutant core particles with 32P-
labeled dATP and unlabeled dNTPs, and tested whether these
mutants could incorporate dNTP and may synthesize short
oligomeric nucleic acids. We foresaw three possible outcomes:
(1) the mutant P proteins are able to incorporate dNTPs and
synthesize DNA oligomers; (2) the mutant P proteins are able
to incorporate dNTPs but fail to synthesize DNA; or (3) the
mutant P proteins are unable to incorporate dNTPs. In the first
two cases, core particles containing P proteins with dNTP
incorporation activity would be radiolabeled during EPA with
a radiolabeling intensity roughly corresponding to the length
of the DNA synthesized. In the third case, no radiolabeling
would be seen. Consistent with the previous report (Kim et al.,
2004), HBV wt core particles showed strong labeling in-
tensity, TP Y65F core particles showed weak labeling, and
RT YMHA core particles failed to label, representing DNA
synthesis, oligomer synthesis, and no dNTP incorporation,
respectively (Fig. 2C). Furthermore, RT F436G and RT
F436V mutant core particles showed weak but detectable
labeling (Fig. 2C), indicating that the binding cleft mutants
could incorporate dNTPs and synthesize nucleic acids inside
core particles.
The 32P-dATP labeling intensity of the RT F436V mutant
core particles was always stronger than that of the RT F436G
and TP Y65F mutant core particles, but weaker than that of the
HBV wt core particles (Figs. 2C and 3), suggesting that the
nucleic acids synthesized by RT F436V mutant P protein might
be longer than the oligomer synthesized by TP Y65F mutant P
protein (Kim et al., 2004), even though the full length of HBV
DNA was not detected (Fig. 2B).
Since both Southern blot analysis and EPA (Figs. 2B and
C) suggested that the nucleic acids synthesized by RT F436G
and RT F436V mutants may not be full length, we examined
whether the nascent nucleic acids synthesized by these
mutants could translocate to DR1 to function as protein
primers, similar to wt TP. We previously demonstrated that
dCTP was not contained in the oligomer synthesized by the
priming-deficient TP Y65F mutant due to lack of translocation
to DR1 (Kim et al., 2004). Furthermore, since the labeling
intensity of RT F436G mutant was always comparable to that
of TP Y65F mutant, we speculated that RT F436G mutant
Fig. 2. HBV core particle formation, pgRNA encapsidation, and HBV DNA synthesis from HBV wt- or mutant-transfected HuH7 cells. (A) RNase Protection Assay
(RPA) to detect encapsidated pgRNA (upper panel) and cytoplasmic pgRNA (lower panel). An in vitro transcribed radiolabeled antisense RNA probe (446 nt) was
hybridized overnight at 50 °C with pgRNA from isolated core particles or 5 μg of total RNA. Samples were digested with RNase, and protected pgRNA (369 nt) was
run on a 5% polyacrylamide-8M urea gel and visualized by autoradiography. (B) Southern blot analysis to detect HBV DNA replication. HBV DNAwas extracted
from isolated core particles and then separated, transferred to nylon membranes, hybridized with a random-primed 32P-labeled HBV-specific probe, and subjected to
autoradiography. Single-, double-stranded linear, and partially double-stranded relaxed circular forms of HBV DNA are marked as SS, DL, and RC, respectively.
Western blot analysis of HBV core particles from a native agarose gel was performed to normalize the transfection efficiencies. Isolated core particles were transferred
to PVDF membranes and incubated with a rabbit anti-HBc antibody, and the results were visualized using an HRP-conjugated secondary antibody and ECL. (C) An
endogenous polymerase assay (EPA) was performed with 32P-dATP. Core particles isolated from HBV wt- and mutant-transfected HuH7 cells were incubated
overnight with EPA reaction buffer supplemented with 10 μCi of α-32P-dATP (3000 Ci/mmol) and unlabeled dCTP, dGTP, and dTTP at 37 °C. The samples were
electrophoresed on a 1% native agarose gel, and then subjected to autoradiography. Western blot analyses of core particles were performed to normalize the
transfection efficiencies. The labeling intensities of isolated core particles by α-32P-dATP were measured with Fujifilm Image Gauge V4.0 program. (D) EPA was
performed with 32P-dCTP as described in panel C except that unlabeled dATP, dGTP, and dTTP were supplied. Western blot analyses of core particles were performed
to normalize the transfection efficiencies. The labeling intensities of isolated core particles by α-32P-dCTP were measured with Fujifilm Image Gauge V4.0 program.
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might not incorporate 32P-dCTP. Using EPA with 32P-dCTP
and unlabeled dNTPs, we therefore examined whether RT
F436G and RT F436V mutants could incorporate 32P-dCTP
(Fig. 2D). As expected, TP Y65F mutant could incorporate
only a background level of 32P-dCTP (Fig. 2D). However, RT
F436G and RT F436V mutant core particles were labeled with
32P-dCTP comparable to 32P-dATP (Figs. 2C and D),
suggesting that the nucleic acids synthesized by the RT
F436G and RT F436V mutants may be covalently linked to
the mutant P proteins and be translocated to DR1 to elongate
the minus-strand nucleic acids.
Priming reaction of the HBV P protein RT mutants
We next indirectly examined that the nucleic acids
synthesized by the RT F436G and RT F436V mutants were
covalently linked to the mutant P proteins. In brief, core
particles isolated from HBV wt- or mutant-transfected HuH7cells were subjected to EPA with 32P-dATP and dNTPs, and
they were then split in half and electrophoresed on two identical
1% native agarose gels. The gels were then treated with either
2% SDS (to disrupt the core particles) or distilled water
(control). The gels were then blotted to nylon membranes and
subjected to the core particle Western blot analysis to ensure that
identical amounts of core particles had been loaded (Fig. 3,
bottom panels).
We hypothesized that labeled long strand of nucleic acids
linked to the P protein by phosphodiester bonds (e.g. wt HBV,
positive control) would resist washing-out by 2% SDS
treatment, whereas oligomers that were not covalently linked
to the P protein (e.g. TP Y65F (Kim et al., 2004), negative
control) would be removed from 2% SDS-treated gel, however,
would be retained in the water-treated gel. The labeling
intensities of HBV wt and mutant core particles from the
water-soaked gel were similar to those seen on a comparable
dried gel (compare Figs. 2C and 3, upper left and middle left
panels). As expected, disruption of core particles by 2% SDS
Fig. 3. The nucleic acids synthesized by the RT F436G and RT F436Vmutants are covalently linked to the mutant P proteins. Core particles isolated from HBVwt- and
mutant-transfected HuH7 cells were incubated overnight at 37 °C with EPA reaction buffer supplemented with 10 μCi of α-32P-dATP (3000Ci/mmol) and unlabeled
dNTPs. The reactions were then split in half and electrophoresed on two identical 1% native agarose gels, which were subjected to in-gel treatment with either 2% SDS
(disruption) or distilled water (control) for 1 h. The particles were then transferred to nylon membranes, and the labeling intensities of HBV wt and mutant core
particles were determined by autoradiography. Western blot analysis was performed to ensure that identical amounts of core particles were loaded onto each gel. The
priming-deficient TP Y65F mutant was used as a control. Their labeling intensities were measured with Fujifilm Image Gauge V4.0 program.
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wt HBV compared to the water-soaked control (Fig. 3, upper
panel), but significantly reduced the labeling intensity of TPFig. 4. Endogenous polymerase assays (EPAs) with 32P-ATP, 32P-UTP, 32P-GTP, o
particles isolated from HBV wt- and mutant-transfected HuH7 cells were incubated o
ATP (3000 Ci/mmol) and unlabeled dNTPs, electrophoresed on a 1% native agarose
described in panel A except that unlabeled GTP, dCTP, and dTTP were supplied. (C)
rNTPs were supplied. (D–F) EPAs were performed with 10 μCi of α-32P-UTP (6000 C
(3000 Ci/mmol) (F) and unlabeled rNTPs as described in panel C. Western blot ana
normalize the transfection efficiencies.Y65F core particles to almost invisible level (Fig. 3, upper right
and middle right panels). Interestingly, 2% SDS treatment
reduced slightly the signals of RT F435G and RT F436V fromr 32P-CTP. (A) EPA was performed with 32P-ATP and unlabeled dNTPs. Core
vernight at 37 °C with EPA reaction buffer supplemented with 10 μCi of α-32P-
gel, and subjected to autoradiography. (B) EPAwas performed with 32P-ATP as
EPAwas performed with 32P-ATP as described in panel A except that unlabeled
i/mmol) (D), 10 μCi of α-32P-GTP (3000 Ci/mmol) (E), or 10 μCi of α-32P-CTP
lyses of core particles from wt- and mutant-transfected cells were performed to
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TP Y65F signal to an almost undetectable level (Fig. 3, middle
panels). This result indicates that the newly synthesized nucleic
acids by dNTP-binding cleft mutant P proteins may be
covalently linked to the P proteins, further suggesting that the
mutant P proteins had unaltered TP function, and thus may be
translocated to DR1 in vivo, allowing additional nucleic acid
elongation. Unlike previous study with DHBV RT dNTP-
binding cleft mutants expressed in LMH cells which failed to
demonstrate the synthesis of nucleic acids (Beck et al., 2002),
our present study demonstrated the synthesis of nucleic acids
(Figs. 2C and D, 3, and 4).
rNTP incorporation by RT dNTP-binding cleft mutant P
proteins
To examine the rNTP incorporation capacities of these
mutants, the mutants were subjected to EPA as described above,
except that 32P-ATP was used as the radioactive nucleotide
instead of 32P-dATP. Our results revealed that the RT F436G
and RT F436V mutant core particles were labeled with 32P-ATP
when the corresponding unlabeled dNTPs (dGTP, dCTP, and
TTP) were supplied, whereas HBV wt, TP Y65F, and RT
YMHA core particles did not show nucleotide incorporation
under these conditions (Fig. 4A). Additional EPAs were
performed using 32P-ATP supplemented with GTP, dCTP, and
TTP (Fig. 4B), or with only rNTPs and no dNTP (Fig. 4C). As
shown in Figs. 4B and C, the RT F436G and RT F436V mutant
core particles still showed 32P-ATP labeling, whereas the HBV
wt, TP Y65F, and RT YMHA core particles did not.
We next performed EPAs with wt and mutant core particles
in the presence of 32P-UTP (Fig. 4D), 32P-GTP (Fig. 4E), or
32P-CTP (Fig. 4F) and appropriate unlabeled rNTPs. Consistent
with the above results, the RT F436G and RT F436V mutant
core particles were successfully labeled with 32P-rNTPs, while
the other core particles tested were not (Figs. 4D–F). Consistent
with the results shown in Figs. 4A and B, additional EPA
experiments performed, using 32P-UTP, 32P-GTP, and 32P-CTP
supplemented with unlabeled dNTP mixture or unlabeled
dNTP+rNTP mixture, showed successful labeling of the RT
F436G and RT F436V mutant core particles, but not the other
tested core particles (data not shown).
In some cases, 32P-rNTP labeling intensities of RT F436G
mutant core particles were slightly stronger than those of the RT
F436V mutant core particles (Figs. 4D and E). However, we
were unable to conclusively establish which mutant core
particles incorporated rNTPs more efficiently (Fig. 4). Since
Val is larger than Gly, Val in the dNTP-binding cleft region of
RT could occupy more space in the dNTP-binding cleft than
Gly. This speculation is partly supported by a previous study
showing that different rNTP incorporation levels are associated
with various sizes of substituted amino acids in an in vitro
priming assay using DHBV RT dNTP-binding cleft mutant P
proteins (Beck et al., 2002). Although future studies are
required to clarify the quantitative preference of mutant P
proteins between deoxyribonucleotides and ribonucleotides, the
present results are consistent with the notion that replacement ofbulky Phe 436 with a smaller amino acid (Gly or Val) reduces
steric hindrance at the dNTP-binding cleft and abrogates the
exclusion of rNTPs from binding. Our results revealed that the
RT mutant core particles could incorporate all species of rNTPs
into growing nucleic acid chain (Fig. 4), indicating that the
HBV RTacquired RNA polymerase-like activity after change of
a single amino acid.
Our finding also indicates that substitution of Gly or Val for
the larger Phe at the dNTP-binding cleft expanded the
substrate selectivities, allowing the mutant P proteins to
incorporate rNTPs in addition to dNTPs. Notably, however,
the 32P-rNTP labeling intensities of the dNTP-binding cleft RT
mutants were weak (Fig. 4) compared to the labeling intensity
seen with 32P-dATP (Figs. 2C and 3), suggesting that the
mutant P proteins might not be able to extend the ribonucleic
acids when rNTPs were supplied instead of dNTPs. This result
further indicates that the RT dNTP-binding cleft mutant core
particles would be unable to synthesize pure RNA. Although
the RT F436G and RT F436V mutant core particles could
incorporate 32P-dATP and 32P-dCTP (Figs. 2C and D and 3),
these mutants did not produce pure HBV DNA (Fig. 2B).
Since all of our experiments were conducted with core
particles isolated from transfected HuH7 cells, unlike those
previously reported in vitro-expressed RTs (Beck et al., 2002;
Cases-Gonzalez et al., 2000; Gao et al., 1997), it is reasonable
to speculate that core particles containing mutant HBV P
proteins might synthesize nucleic acids containing both
deoxyribonucleotides and ribonucleotides in the authentic
replicating HuH7 cells which contained high concentrations
of endogenous dNTPs and rNTPs pools (Beck and Nassal,
1998; Joyce and Steitz, 1994).
Extending our previous observation of primer-independent
initiation of HBV DNA synthesis by the HBV P protein (Kim
et al., 2004), we showed in the present study that rNTP
incorporation capacity could be introduced by a single amino
acid substitution in the dNTP-binding cleft of the HBV P
protein, thus indicating that a single amino acid substitution
can blur the properties of a DNA polymerase toward those of
an RNA polymerase. Also, the in vitro-expressed DHBV P
protein was found to have several features in common with the
T7 RNA polymerase (Schaaf et al., 1999). These findings
collectively indicate that the HBV P protein can acquire RNA
polymerase-like properties following only a minor modifica-
tions, further suggesting that, despite complex classification of
polymerases, such as into RNA- and DNA-dependent RNA
polymerases and RNA- and DNA-dependent DNA poly-
merases, the HBV RT appears to have originated as a whole
from the same ancestral origin as the polymerase group (Gao
et al., 1997).
We are at a loss to explain the reason of why these HBV RT
dNTP-binding cleft mutants have never before been observed
during viral infection or replication, because these RT mutants
can be made with a single amino acid substitution. It is highly
likely that the HBV P proteins may have additional amino acids
or regions capable of preventing RNA elongation, thus ensuring
that no such viruses could emerge by making these viruses as
dead viruses.
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DNA constructs
The HBV subtype adw R9 plasmid, pPB, was used as the wt
HBV construct as previously described (Kim et al., 2004). To
generate the RT F436G mutant of the HBV, Phe 436 (TTT) was
changed to Gly (GGT) using a fusion PCR technique. Forward
mutagenic primer HBV 79 (5′-GAATATGATAACCCGCCG-
CAGACACATCCAG-3′, targeting nt 415 to 375) and reverse
primer HBV 3 (5′-CCACCTCTAAGAGACAGTC-3′, target-
ing nt 3183 to 3201) were used for one PCR reaction, while a
second PCR reaction was performed with reverse mutagenic
primer 78 (5′-GTCTGCGGCGGGTTATCATATTCCTCTT-
CATC-3′, targeting nt 383 to 414) and forward primer HBV 8
(5′-CACGATCGTGTACAGACTTG-3′, targeting nt 783 to
764). The resulting PCR products (443 and 369 bp, res-
pectively) were combined by fusion PCR. The fusion PCR
product was digested with XcmI and EcoRI, and then cloned
into the corresponding enzyme restriction site of pPB (Kim
et al., 2004) to yield the HBV RT mutant, RT F436G. In order
to construct the RT F436V mutant of the HBV, Phe 436 (TTT)
was changed to Val (GTT) using the same strategy as de-
scribed above and mutagenic primers HBV 80 (reverse, 5′-
GTCTGCGGCGGTTTATCATATTCCTCTTCATC-3′) and
HBV 81 (forward, 5′-GAATATGATAAACCGCCGCAGA-
CACAT CCAG).
Cell culture, transfection, and isolation of core particles
HuH7 hepatoma cells were maintained and a total of 8 μg
of plasmid DNA of HBV wt and mutant constructs was
transfected into HuH7 cells as previously described (Kim
et al., 2004). Cytoplasmic core particles were prepared from
transfected-cells as previously described (Kim et al., 2004).
Transfection experiments were repeated more than three
times.
Northern and Southern blotting
Total RNA (5 μg) was denatured and electrophoresed
through a 1% agarose gel containing formaldehyde and
transferred onto a nylon membrane. Membrane-bound RNA
was hybridized to a 32P-labeled random-primed probe specific
for the indicated HBV sequence or glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). To analyze HBV DNA synthesis,
core DNA was extracted and Southern blot was performed as
described previously (Kim et al., 2004).
Western blotting of core particle
Isolated core particles were electrophoresed on a 1% native
agarose gel and then Western blot analysis was performed as
described previously using an anti-HBc antibody (DAKO)
(Koschel et al., 2000). Transfection efficiencies were normal-
ized by Western blotting of core particle throughout the
experiments.RNase protection analysis (RPA)
For analysis of cytoplasmic and encapsidated pgRNA, RPA
was performed as previously described (Kim et al., 2004). The
446 nt of the HBV sequence (nt 1805 to 2187) was synthesized
in vitro and the protected sequence was 369 nt long (Kim et al.,
2004).
Endogenous polymerase assay (EPA)
Isolated core particles were incubated overnight at 37 °C in
EPA reaction buffer (50 mM Tris–HCl, 75 mM NH4Cl, 1 mM
EDTA, 25 mMMgCl2, 0.1% β-mercaptoethanol, 0.5% Nonidet
P-40) supplemented with 0.5 mM each of dCTP, dGTP, TTP,
and 10 μCi α-32P-dATP (Kim et al., 2004). For modified EPA,
which was used to test the incorporation of rNTP into the HBV
core particles, α-32P-ATP (specific activity, 3000 Ci/mmol),
α-32P-GTP (specific activity, 3000 Ci/mmol), α-32P-CTP
(specific activity, 3000 Ci/mmol), or α-32P-UTP (specific
activity, 6000 Ci/mmol) was used for EPA along with
appropriate unlabeled dNTPs and/or rNTPs. The resulting
32P-labeled reaction mixtures were electrophoresed on a 1%
native agarose gel and then subjected to dry gel autoradiography
(Kim et al., 2004). To examine whether the nucleic acids
synthesized by the HBV RT mutants were covalently linked to
the TP region of the P protein, the 32P-labeled reaction
mixtures were electrophoresed on a 1% native agarose gel. The
gel was then exposed to 2% SDS for 1 h to disrupt the
electrophoresed core particles and release nucleic acids that
were not linked covalently to HBV P protein. As a control, a
corresponding core particle-containing agarose gel was incu-
bated in distilled water for 1 h. The gels were then rinsed with
distilled water, transferred to nylon membranes, and subjected
to autoradiography.
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